Natco Pharma invests USD 8 mn in bio-tech firm eGenesis

In March 2024, eGenesis announced the world's first porcine kidney transplant in a living patient. The transplant was authorized by the U.S. Food & Drug Administration (FDA) under the Expanded Access pathway.